The health care reform law turned 2 years old last week and goes before the Supreme Court this week to decide on constitutionality of it. Now might be good time to see who’s benefitted from it, and who hasn’t. Health insurers beat the Wall Street analysts forecast every quarter since the start of 2009. More insured patients mean more prescriptions, which are supplied by drug and biotech companies. Medical researchers will get billions to test drug and treatments. The Bureau of Labor Statistics figures the number of actuaries will rise 21% over a decade. Amongst those taking a hit from the law, hospitals will face $155 billion in Medicare reimbursement cuts through 2020. The Congressional Budget Office estimates state medical programs will have to spend an additional $60 billion through 2021. Radiologists will lose income because the law ties compensation to end results, rather than the number of tests ordered.